Skip to main content
. 2016 Sep 22;2016:8294805. doi: 10.1155/2016/8294805

Table 2.

Summary of adverse events.

5-ALA-SFC 
n = 35
Placebo 
n = 18
Subjects reporting at least one event 16 (45.7%) 5 (27.8%)
Subjects reporting at least one related event 7 (20%) 3 (16.7%)
Subjects reporting at least one severe event 0 0
Subjects reporting at least one event leading to study discontinuation 6 (17.1%) 1 (5.6%)

p = 0.206.